Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fu...(8% Asia Pacific 104....)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
Date:2/9/2009
8% Asia Pacific 104.5 102.9 1.6% 0.2% Other (3) 49.6 60.2 (17.5)% (6.6)% ---- ---- Total revenues $811.3 $789.0 2.8% 6.6% ====== ====== Year Ended December 31, Constant ------------ Reported Currency 2008 2007 Growth % Growth % ---- ---- -------- -------- Revenues by geography: United States $1,542.1 $1,425.0 8.2% 8.2% Europe 687.1 605.4 13.5% 8.7% Emerging Markets (2) 278.3 224.1 24.2% 24.2% Asia Pacific 383.7 316.1 21.4% 15.9% Other (3) 207.7 190.7 8.9% 6.2% ----- ----- Total revenues $3,098.9 $2,761.3 12.2% 10.4% ======== ======== (1) Amounts may not foot due to rounding (2) Includes Eastern Europe, Russia, Middle East, Africa and India (3) Includes Canada and Latin America BECKMAN COULTER, INC. SALES MIX (1) (in millions) (unaudited) 2008 ---- Qtr 1 Qtr 2 Qtr 3 Qtr 4 Year ----- ----- ----- ----- ---- Recurring revenue $579.3 $618
'/>"/>
| SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Post Your Comments:
(Date:11/20/2009)...irstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq...cuit Court of Appeals reversed a U.S. District Cou...ursue all of its claims against The Lash Group, se...l. CTI filed a complaint against The Lash Group, ...for CTI,s product TRISENOX, in 2007 seeking $22.8 ...
(Date:11/19/2009)...Call/ -- Omeros Corporation (Nasdaq: OMER ) today...rd quarter ended September 30, 2009. For the three...a net loss of $3.9 million, or $1.34 per share, as...per share, for the same period in 2008. For the ni...ported a net loss of $15.5 million, or $5.29 per s...
(Date:11/19/2009)...., Nov. 19 Arlington Medical Resou...ading driver of antibiotic selection in nosocomial...ainst gram-positive and gram-negative pathogens. D...comial pneumonia, surveyed European physicians rev...de appropriate coverage against common pathogens, ...
(Date:11/19/2009)...by latest award for revolutionary hearing aid. , ...r 16, 2009 -- Popular Science Magazine has named t...InSound Medical a winner of its coveted Best of Wh... Chosen from thousands of entrant... canal for up to four months while providing natur...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3[0] Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group[0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights[0] Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe[0] Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award
.... 8 RxElite, Inc. (OTC,Bulletin Board: RXEI), a d...generic prescription drug products, announced toda...agreement, it has voluntarily instructed all named... Registration Statement on,Form SB-2 (File No. 333...her advised. This release corrects and should repl...
... SRA footprint in human health services around the...Va., Jan. 8 As part of its overall,expansion in n...today,announced the appointment of Timothy J. Atki...President and Chief Financial Officer (CFO) of its...was formed in October 2007 to,expand SRA,s footpri...
...etts, January 8 Primera Biosystems,Inc., an emerg...ams in,infectious disease and oncology, announced ...B financing led by Abingworth and joined by Interw...ogy Development Corporation,(MTDC), MPM Capital, B...ated in the round., "Primera plans to use this fi...
Other Biology Technology:/CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 3Primera Biosystems Raises $21 Million in Series B Private Round 2Primera Biosystems Raises $21 Million in Series B Private Round 3(Date:11/19/2009)...ofessor of paleontology in the McMicken College of...he University of Chicago publish their research in..."Epicontinental Seas Versus Open-Ocean Settings: T..., For many years, paleobiological researchers int...d on charting the many ups (evolutionary radiation...
(Date:11/19/2009)... Director,s T-R01 Award , Speedier Lab Testing Wi...frey, associate professor of pharmacology at Weill...rchers to win a prestigious NIH Director,s Transfo...Health. Dr. Jaffrey and his colleagues are develop...at may some day speed up lab testing by instantane...
(Date:11/19/2009)...ofessor in the Fischell Department of Bioengineeri...ence Research and Technology Review Day with a tis...and other types of tissue for implantation. , Fi...nted in an eight minute pitch by faculty members a..., held November 12 at the University of Maryland. ...
Breaking Biology News(10 mins):Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 1Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 2HPV Tied to Rare Head and Neck Cancer 59233 1HPV Tied to Rare Head and Neck Cancer 59233 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3...ESTON, Virginia, February 10 WCC Smart Search &am...search and match software, today,announced its par...iometrics,Operations and Support Services - Unrest...ogram twelve designated contractors will compete f...97 million to provide,biometric services and solut...
... economy isn,t just squeezing the middle class on ...study by the Wildlife Conservation Society (WCS) a...urprising correlation between "middle class" commu...iously, areas with both low and high socio-economi...Appearing in the latest edition of Current Biolog...
...real, February 10, 2009 The year 2009 marks the 1... of the Species " a seminal book that permeated c... February 12 also marks the bicentennial anniversa...ontral professors can comment on how the Father of...philosophy to psychology: , Darwin and biology ,...
Other Biology News:WCC Smart Search & Match to Support U.S. Army's BOSS-U Program 2Study says 'middle class' coral reef fish feel the economic squeeze 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 3Darwin's seminal impact on biology, anthropology, philosophy and psychology 4Goat Anti-MLH3 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products:Goat Anti-MLH3 Polyclonal Antibody, Unconjugated from AbcamRabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagentsMouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegendRabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |